High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
Complete cancer regression occurs in a subset of patients following adoptive T cell therapy
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer… - Proceedings of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Complete cancer regression occurs in a subset of patients following adoptive T cell therapy
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
[HTML][HTML] High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins… - Proceedings of the …, 2020 - ncbi.nlm.nih.gov
Complete cancer regression occurs in a subset of patients following adoptive T cell therapy
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins… - Proceedings of the …, 2020 - ui.adsabs.harvard.edu
Adoptive T cell therapy (ACT) is an experimental cancer immunotherapy with partial clinical
responses (∼ 20%). A mechanistic understanding of T cell receptors (TCR) isolated from …
responses (∼ 20%). A mechanistic understanding of T cell receptors (TCR) isolated from …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins, E Tran… - Proceedings of the …, 2020 - JSTOR
Complete cancer regression occurs in a subset of patients following adoptive T cell therapy
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins, E Tran… - Proc. Natl. Acad. Sci …, 2020 - osti.gov
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
(Journal Article) | OSTI.GOV skip to main content Sign In Create Account Show search …
(Journal Article) | OSTI.GOV skip to main content Sign In Create Account Show search …
Erratum: High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D (Proc. Natl. Acad. Sci.(2020) 117 (12826-12835
MJW Sim, J Lu, M Spencer… - … of the National …, 2020 - providence.elsevierpure.com
Abstract The authors note, In Table 1 and Fig. 3 G and H, the frequencies of TCR9b and
TCR9c in the TIL infusion and in the periphery were inadvertently switched. The correct …
TCR9c in the TIL infusion and in the periphery were inadvertently switched. The correct …
High affinity oligoclonal TCRs define effective adoptive T-cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins… - The Journal of …, 2020 - journals.aai.org
Complete regression of cancer has been observed in a subset of patients following adoptive
T-cell transfer (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TIL). However, the …
T-cell transfer (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TIL). However, the …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
MJW Sim, J Lu, M Spencer, F Hopkins, E Tran… - Proceedings of the …, 2020 - cir.nii.ac.jp
抄録< jats: p> Complete cancer regression occurs in a subset of patients following adoptive
T cell therapy (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the …
T cell therapy (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the …
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D.
MJW Sim, J Lu, M Spencer, F Hopkins… - Proceedings of the …, 2020 - europepmc.org
Complete cancer regression occurs in a subset of patients following adoptive T cell therapy
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …
(ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). However, the low success …